← Open Payments lookup

BETH EMAMI: Open Payments

NPI 1417986365 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$506 in 20 payments from 7 companies in 2025. Trend: 2023 $1,443 · 2024 $359 · 2025 $506

Food & beverage: $406Education: $100
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.7$162
Astellas Pharma US Inc3$138
ABBVIE INC.3$78
MILLICENT US INC4$62
180 Medical, Inc.1$29
MAYNE PHARMA COMMERCIAL LLC1$21
Medtronic, Inc.1$18

Products named: GEMTESA, BOTOX, INTRAROSA, Veozah, GENTLECATH, ALTAVIVA, FEMLYV.

Industry payments across MD — which companies pay providers there.